DekaBank Deutsche Girozentrale
SAGE

DekaBank Deutsche Girozentrale’s Sage Therapeutics SAGE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,220
Closed -$460K – 1314
2025
Q4 		$460K Hold
22,220
– – ﹤0.01% 1021
2025
Q3 		$455K Hold
22,220
– – ﹤0.01% 1006
2025
Q2 		$203K Hold
22,220
– – ﹤0.01% 1122
2025
Q1 		$182K Hold
22,220
– – ﹤0.01% 1132
2024
Q4 		$121K Hold
22,220
– – ﹤0.01% 1226
2024
Q3 		$160K Hold
22,220
– – ﹤0.01% 1200
2024
Q2 		$236K Hold
22,220
– – ﹤0.01% 1131
2024
Q1 		$420K Hold
22,220
– – ﹤0.01% 1035
2023
Q4 		$488K Hold
22,220
– – ﹤0.01% 1042
2023
Q3 		$461K Hold
22,220
– – ﹤0.01% 1029
2023
Q2 		$1.05M Hold
22,220
– – ﹤0.01% 868
2023
Q1 		$917K Hold
22,220
– – ﹤0.01% 889
2022
Q4 		$848K Hold
22,220
– – ﹤0.01% 920
2022
Q3 		$868K Hold
22,220
– – ﹤0.01% 910
2022
Q2 		$711K Hold
22,220
– – ﹤0.01% 954
2022
Q1 		$762K Buy
22,220
+450
+2% +$16.9K ﹤0.01% 965
2021
Q4 		$913K Buy
21,770
+500
+2% +$20.9K ﹤0.01% 953
2021
Q3 		$934K Hold
21,270
– – ﹤0.01% 919
2021
Q2 		$1.18M Hold
21,270
– – ﹤0.01% 874
2021
Q1 		$1.54M Buy
21,270
+1,550
+8% +$127K 0.01% 768
2020
Q4 		$1.7M Sell
19,720
-1,000
-5% -$73.7K 0.01% 708
2020
Q3 		$1.21M Buy
+20,720
New +$1.05M 0.01% 707
2020
Q1 		– Sell
-1,031
Closed -$75K – 1141
2019
Q4 		$75K Sell
1,031
-20,920
-95% -$2.57M ﹤0.01% 1067
2019
Q3 		$3.13M Sell
21,951
-24,280
-53% -$4.06M 0.02% 438
2019
Q2 		$8.34M Sell
46,231
-3,713
-7% -$634K 0.04% 342
2019
Q1 		$8.23M Buy
49,944
+27,980
+127% +$4.05M 0.05% 343
2018
Q4 		$1.93M Sell
21,964
-27,980
-56% -$3.2M 0.01% 544
2018
Q3 		$8.23M Buy
49,944
+28,664
+135% +$4.42M 0.05% 346
2018
Q2 		$3.23M Buy
21,280
+1,220
+6% +$192K 0.02% 489
2018
Q1 		$3.19M Sell
20,060
-43,390
-68% -$7.37M 0.02% 474
2017
Q4 		$5.35M Hold
63,450
– – 0.04% 360
2017
Q3 		$5.35M Hold
63,450
– – 0.04% 361
2017
Q2 		$5.01M Sell
63,450
-10,000
-14% -$723K 0.04% 380
2017
Q1 		$4.76M Buy
73,450
+40,400
+122% +$2.37M 0.04% 352
2016
Q4 		$1.62M Buy
33,050
+7,600
+30% +$358K 0.02% 471
2016
Q3 		$1.16M Buy
25,450
+8,500
+50% +$346K 0.01% 518
2016
Q2 		$497K Buy
16,950
+3,100
+22% +$103K 0.01% 681
2016
Q1 		$432K Sell
13,850
-800
-5% -$28.2K 0.01% 685
2015
Q4 		$858K Buy
14,650
+350
+2% +$17.3K 0.01% 585
2015
Q3 		$605K Buy
14,300
+500
+4% +$30.8K 0.01% 644
2015
Q2 		$1.01M Buy
13,800
+1,800
+15% +$116K 0.01% 568
2015
Q1 		$603K Buy
+12,000
New +$516K 0.01% 674

Other funds holding SAGE

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SAGE Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Sage Therapeutics (SAGE) in Q1 2026, closing a stake of 22,220 shares — an estimated $460K sold.

DekaBank Deutsche Girozentrale first reported a position in SAGE in Q1 2015 and held it in 42 quarters. The position peaked at $8.34M in Q2 2019. 1 fund tracked by Wall St. Rank holds SAGE as of Q1 2026.

  • DekaBank Deutsche Girozentrale reported no remaining Sage Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 22,220 Sage Therapeutics shares in Q1 2026, an estimated $460K.
  • DekaBank Deutsche Girozentrale first reported a position in Sage Therapeutics in Q1 2015 and held it in 42 quarters.
  • DekaBank Deutsche Girozentrale's Sage Therapeutics position peaked at $8.34M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Sage Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.